Wednesday, July 8, 2026

Patent intelligence · US

US 11975047

Methods for storing and warming purified corticotropin compositions

granted A61KA61K38/22A61K38/2228A61K38/35
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 18
Applicant portfolio 7
Patent details — US 11975047
Jurisdiction
US
Status
granted
Grant date
May 7, 2024
Expiration
May 2, 2044
Claims
30
CPC classes
A61K, A61K38/22, A61K38/2228, A61K38/35
View on Google Patents ↗

Quick answer

US 11975047 (Methods for storing and warming purified corticotropin compositions) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted May 7, 2024. Expires May 2, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
30
CPC classes
A61K, A61K38/22, A61K38/2228, A61K38/35, A61K47/10, A61K47/42

More from ANI Pharmaceuticals, Inc.

Related pharmaceutical patents in our USPTO index.

  1. US 12350245

    Stable oral suspensions of baclofen

    ANI Pharmaceuticals, Inc. · Expires Jul 3, 2045

    granted
  2. US 12324787

    Kits for preparing and delivering purified corticotropin

    ANI Pharmaceuticals, Inc. · Expires Jun 5, 2045

    granted
  3. US 12233105

    Methods for storing and warming purified corticotropin compositions

    ANI Pharmaceuticals, Inc. · Expires Feb 20, 2045

    granted
  4. US 12133831

    Kits for preparing and delivering purified corticotropin

    ANI Pharmaceuticals, Inc. · Expires Oct 31, 2044

    granted
  5. US 12102662

    Methods for storing and warming purified corticotropin compositions

    ANI Pharmaceuticals, Inc. · Expires Sep 26, 2044

    granted
  6. US 11857524

    Stable oral suspensions of baclofen

    ANI Pharmaceuticals, Inc. · Expires Dec 28, 2043

    granted

Frequently asked questions

What is US patent 11975047?

US 11975047 (Methods for storing and warming purified corticotropin compositions) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted May 7, 2024. Expires May 2, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 11975047?

ANI Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.

When does US 11975047 expire?

Our index shows an expiration date of May 2, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.